Glutamate modulation of dopamine measured in vivo with positron emission tomography (PET) and 11C-raclopride in normal human subjects

Neuropsychopharmacology

Volumn 18, Issue 1, 1998, Pages 18-25

  Smith, Gwenn S ^a   Schloesser, Ralf ^a   Brodie, Jonathan D ^a   Dewey, Stephen L ^b   Logan, Jean ^b   Vitkun, Stephen A ^c   Simkowitz, Philip ^a   Hurley, Arlene ^a   Cooper, Thomas ^d   Volkow, Nora D ^b   Cancro, Robert ^a  

^a NEW YORK UNIVERSITY   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

11C Raclopride; Dopamine; Glutamanate; Ketamine; Positron emission tomography

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR; GLUTAMIC ACID; HOMOVANILLIC ACID; HYDROCORTISONE; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROLACTIN;

ADULT; ARTICLE; CEREBELLUM; CLINICAL TRIAL; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MODULATION; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; CARBON RADIOISOTOPES; DOPAMINE; DOPAMINE ANTAGONISTS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; HOMOVANILLIC ACID; HUMANS; KETAMINE; MAGNETIC RESONANCE IMAGING; MALE; NEOSTRIATUM; PROLACTIN; RACLOPRIDE; REFERENCE VALUES; SALICYLAMIDES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031930047     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(97)00092-4     Document Type: Article

References (50)

1. Blin J, Denis A, Yamaguchi T, Crouzel C, MacKenzie E, Baron J PET studies of [18F]-methyl-MK-801, a potential NMDA receptor complex radioligand. Neurosci Lett. 121:1991;183-186.
2. Burns R, Lerner S The effects of phencyclidine in man. A review Domino E PCP(Phencyclidine). 1981;449-469. Historical and Current Perspectives. Ann Arbor, MI, NPP Books.
3. Carter C Topographic distribution of possible glutamatergic pathways from the frontal cortex to the striatum and substantia nigra in rats. Neuropsychopharmacology. 21:1982;379-383.
4. Choi D Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
5. Cohen M, Chan S, Bhargava H, Trevor A Inhibition of mammalian brain acetylcholinesterase by ketamine. Biochem Pharmacol. 23:1974;1647-1652.
6. Corssen G, Domino E Dissociative anesthetics. Further pharmacologic studies and first clinical experience with the phencyclidine derivative Cl-581 Anesth Analg. 45:1966;29-40.
7. Coyle J Kainate acid. Insights into excitatory mechanisms causing selective neuron degeneration Ciba Found Symp. 126:1987;186-203.
8. 18F-N-methylspiroperidol binding in the baboon brain using positron emission tomography (PET). Synapse. 7:1991;324-327.
9. Dewey S, Smith G, Logan J, Alexoff D, King P, Pappas N, Ashby C, Brodie J The serotonergic-dopaminergic interaction in vivo with positron emission tomography (PET) and microdialysis. J Neurosci. 15:1995;821-829.
10. 11C-raclopride is altered by drugs that modify synaptic dopamine levels. Synapse. 13:1993;350-356.
11. Dewey SL, Smith G, Logan J, Simkowitz P, Brodie JD, Fowler JS, Volkow N, Wolf AP Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography (PET) in normal human subjects. Proc Natl Acad Sci. 90:1993;11816-11820.
12. 11C-raclopride and positron emission tomography. J Neurosci. 12:1992;3773-3780.
13. Ellison G The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias. Brain Res Rev. 20:1995;250-267.
14. 2 receptor binding in the living human brain by PET. Science. 231:1986;258-261.
15. Farde L, Eriksson L, Blomquist G, Halldin C Kinetic analysis of central [11C]-raclopride binding to D2-dopamine receptors studied by PET - A comparison to the equilibrium analysis. J Cereb Blood Flow Metab. 9:1989;696-708.
16. French E Phencyclidine and the midbrain dopamine system. Electrophysiology and behavior Neurotoxicol Teratol. 16:1994;355-362.
17. Gao X, Shirakawa F, Tamminga C Delayed regional metabolic actions of phencyclidine. Eur J Pharmacol. 241:1993;7-15.
18. Gribkoff V Electrophysiological evidence for N-methyl-D-asparate excitatory amino acid receptors in the rat supraoptic nucleus in vitro. Neurosci Lett. 131:1991;260-262.
19. 1 receptors. J Nucl Med. 35:1994;122P.
20. Hollander E, DeCaria C, Nitescu A, Gully R, Suckow R, Cooper T, Gorman J, Klein D, Liebowitz M Serotonergic function in obsessive-compulsive disorder. Arch Gen Psychiatry. 49:1992;21-28.
21. Holthoff V, Koeppe R, Frey K, Paradise A, Kuhl D Differentiation of radioligand delivery and binding in the brain. validation of a two-compartment model for [11C]-flumazenil J Cereb Blood Flow Metab. 11:1991;745-752.
22. Innis R, Mallison R, Al-Tikriti M, Hoffer M, Sybirska E, Seibyl J, Zoghbi S, Baldwin R, Laruelle M, Smith E, Charney D, Henninger G, Elsworth J, Roth R Amphetamine stimulated dopamine release competes in vivo for [123I]-IBZM binding. Synapse. 10:1992;177-184.
23. Javitt D, Zukin S Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 148:1991;1301-1308.
24. Karreman M, Moghaddam B The prefrontal cortex regulates the basal release of dopamine in the limbic striatum. An effect mediated by ventral tegmental area J Neurochem. 66:1996;589-598.
25. Krystal J, Karper L, Seibyl J, Freeman G, Delaney R, Bremner J, Heninger G, Bowers M, Charney D Subanesthetic effects of the non-competitive NMDA antagonist, ketamine, in humans. Arch Gen Psychiatry. 51:1994;199-214.
26. Lahti A, Koffel B, LaPorte D, Tamminga C Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology. 13:1995;9-19.
27. Lahti A, Holcomb H, Medoff D, Tamminga C Ketamine activates psychosis and alters limbic blood flow in schizophrenia. Neuroreport. 6:1995;869-872. b.
28. Logan J, Fowler J, Volkow N, Wolf A, Dewey S, Schleyer D, Macgregor R, Hitzemann R, Bendriem B, Gatley S, Christman D Graphical analysis of reversible radioligand binding from time-activity measurements applied to N-11C-methyl-(-)-Cocaine PET studies in human subjects. J Neurochem. 10:1990;740-747.
29. 11C-raclopride binding in the brain. model simulations and kinetic analysis of PET data J Cereb Blood Flow Metab. 14:1995;995-1010.
30. McBride P, Tierney H, DeMeo M, Chen J, Mann J Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry. 27:1990;1143-1155.
31. McGeer P, McGeer E, Scherrer U, Singh K A glutamatergic corticostriatal path? Brain Res. 128:1977;369-373.
32. Moghaddam B, Gruen R, Roth R, Bunney B, Adams R Effects of l-glutamate on the release of striatal dopamine. In vivo dialysis and electrochemical studies Brain Res. 518:1990;55-60.
33. Monaghan D, Cotman C Distribution of N-methyl-D-aspartate sensitive L-[3H]-glutamate binding sites in the rat brain. J Neurosci. 5:1985;2909-2919.
34. 2 receptors Life Sci. 59:1996;669-678.
35. Nomikos G, Damsma G, Wenkstern D, Fibiger H In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis. Synapse. 6:1990;106-112.
36. Oye I, Hustveit O, Moberg E, Pausen O, Skoglund L The chiral forms of ketamine as probes for NMDA receptor function in humans. Kamewyama T, Nabeshima T, Domino E NMDA Receptor Related Agents. Biochemistry, Pharmacology and Behavior:1991;381-389 NPP Books, Ann Arbor, MI.
37. Sesack S, Pickel V Prefrontal cortical afferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol. 320:1992;145-160.
38. Siegel R Phencyclidine and ketamine intoxication. A study of four populations of recreational users Petersen R, Stillman R Phencyclidine (PCP) Abuse. An Appraisal:1978;119-147 Rockville, NIDA Research Monograph 21. MD, National Institute on Drug Abuse.
39. Smith D, Azzaro A, Zaldivar S, Palmer S, Lee H Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines. Neuropharmacology. 20:1981;391-396.
40. Smith G, Dewey S, Logan J, Brodie J, Simkowitz P, Vitkun S, Volkow N, Alexoff D, Martin T, Jenkins D, Shea C, Fowler J, Wolf A Dopamine modulation of acetylcholine activity measured with positron emission tomography (PET) and 11C-benztropine in the human brain. Soc Neurosci Abs. 20:1994;12.
41. 11C-raclopride in normal human subjects. Am J Psychiatry. 154:1997;490-496.
42. Thomson A, West D, Lodge D An n-methylasparate receptor-mediated synapse in rat cerebral cortex. A site of action of ketamine? Nature. 313:1985;479-481.
43. Ulas J, Cotman C Excitatory amino acid receptors in schizophrenia. Schizophr Bull. 19:1993;105-117.
44. Verma A, Moghaddam B NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats. Modulation by dopamine J Neurosci. 16:1996;373-379.
45. Vincent J, Kartalovski B, Geneste P, Kamenka J, Lazdunski M Interaction of phencyclidine ("angel dust") with a specific receptor in rat brain membrane. Proc Natl Acad Sci. 76:1979;4678-4682.
46. Volkow N, Fowler J, Wang G-J, Dewey S, Schleyer D, MacGregor R, Logan J, Alexoff D, Shea C, Hitzemann R, Angrist B, Wolf A Reproducibility of repeated measures of Carbon-11 raclopride binding in the human brain. J Nucl Med. 34:1993;609-613.
47. Volkow N, Wang G-J, Fowler J, Logan J, Schleyer D, Hitzemann R, Liegerman J, Angrist B, Pappas N, MacGregor R, Burr G, Cooper T, Wolf A Imaging dopamine release in the human brain. Synapse. 16:1994;255-262.
48. Weissman A, Dam M, London E Alterations in local cerebral glucose utilization induced by phencyclidine. Brain Res. 435:1987;29-40.
49. Wolkin A, Angrist B, Wolf A, Brodie J, Wokkin B, Jaeger J, Cancro R, Rotrosen J Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography. Psychopharmacology. 92:1987;241-246.
50. Zukin S, Zukin R Specific [3H]phencyclidine binding in the rat central nervous system. Proc Natl Acad Sci. 76:1976;5372-5376.